Osteoporosis costs EU countries 37 billion every year

April 17, 2013

A new report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations, is the first to describe in detail the epidemiology, burden, and treatment of osteoporosis in all 27 member states of the European Union (EU27).

Published today in Rome in conjunction with the opening of Europe's largest osteoporosis congress, the report 'Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden' shows that as Europe's population ages, fractures due to osteoporosis will result in increasing costs, disability and premature deaths. Approximately 3.5 million new occur annually in the EU. In 2010 alone, fragility fractures resulted in costs of €37 billion.

Osteoporosis is a common condition that causes bones to become weak and fragile. People with osteoporosis are at high risk of breaking a bone, even after a minor fall, bump or a sudden movement. These fractures can have a huge impact on the sufferer, leading to substantial pain, disability and even . Based on data collected in 2010, the report found that 22 million women and 5.5 million men in the EU27 have osteoporosis.

IOF President Professor John Kanis of the WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, stated, "It is very worrying that health systems are unprepared to meet the growing tide of fractures due to osteoporosis. High risk individuals are not being routinely identified and offered treatment. The current model of osteoporosis management is not sustainable as Europe's population ages and fracture incidence and costs increase still further."

Even people who have broken a bone due to osteoporosis and present to hospitals or clinics for care, are not being systematically diagnosed and treated to prevent further fractures. A first fracture doubles the risk of suffering another, making prevention of this kind critical. Safe and cost effective medications to reduce the risk of fracture are widely available throughout Europe. However, one of the startling findings of the report is that, despite the rising number of people in need of treatment, the actual number of patients taking preventive medication is declining.

"The low rate of diagnosis and treatment in high risk individuals is compounded by the fact that, even when prescribed, approximately 50% of patients do not follow their treatment regimen," said Professor Juliet Compston, Professor of Bone Medicine at the University of Cambridge and Chair of the European Osteoporosis Consultation Panel.

Professor Compston went on to say, "It is apparent that Europe's health authorities must make provision in their healthcare planning to deal with the increase in fractures and associated disability. Key elements of any national strategy must include the better implementation of national guidelines, the establishment of fracture liaison services to identify high-risk patients, and improvement of adherence to proven cost-effective treatment by patients."

The report will be available at http://link.springer.com/journal/11657 (open access); a summary of the report is available at http://www.iofbonehealth.org/osteoporosis-european-union-medical-management-epidemiology-and-economic-burden

Several of the key findings are:

  • 22 million women and 5.5 million men in the EU27 have osteoporosis;
  • 43,000 people died as a result of osteoporotic fracture;
  • 3.5 million new fragility fractures are sustained annually, comprising 610,000 hip fractures, 520,000 vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures;
  • The annual direct of new and prior fragility fractures is € 37 billion;
  • The direct costs of caring for new fractures represented 66% of this cost, long-term fracture care 29% and pharmacological prevention 5%;
  • Fractures also accounted for 1.18 million quality-adjusted life years lost during 2010;
  • The costs of fragility are expected to increase by 25% from 2010 to 2025;
  • The majority of individuals who have sustained an -related fracture, or who are at high risk of fracture, are untreated;
  • Despite an increase in the number of individuals requiring treatment, the number of patients on treatment is declining.

Explore further: New study quantifies the enormous cost of fragility fractures in Europe

More information: References:

Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden Arch Osteoporos 2013. Hernlund E, Svedbom A, Ivergard M, Compston J, et. al. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2013 [in press]

EU review panel of the IOF. Osteoporosis in the European Union: A compendium of country-specific reports. Svedbom A, Hernlund E, Ivergard M, et al. Arch Osteoporos 2013 [in press].

Related Stories

New study quantifies the enormous cost of fragility fractures in Europe

March 23, 2012
Researchers at the European Congress of Osteoporosis & Osteoarthritis in Bordeaux have presented new data* which shows that the economic burden of fragility fractures in the 27 member states of the European Union far exceeds ...

Landmark report reveals immense burden of osteoporotic fractures in Europe

June 15, 2011
A new report launched today by the International Osteoporosis Foundation (IOF) in collaboration with the European Federation of Pharmaceutical Industry Associations (EFPIA) reveals that the burden of fractures in Europe has ...

European Guidance for the diagnosis and management of osteoporosis in postmenopausal women

March 21, 2013
A new Guidance recently published by the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the International Osteoporosis Foundation (IOF) reflects the most current advances in the diagnosis and ...

Recommended for you

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.